* Minerva Neurosciences Inc NERV.OQ NERV.O is expected
to show
no change in quarterly revenue when it reports results on
February 20 (estimated) for the period ending December 31 2024
*
* LSEG's mean analyst estimate for Minerva Neurosciences
Inc is
for a loss of $1.05 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $5.00, above its last closing price
of $1.97.
This summary was machine generated February 18 at 14:06 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)